News
Strengthening gene therapy for Huntington’s disease
A single injection of a new treatment has reduced the activity of the gene responsible for Huntington’s disease for several months in a trial in mice.
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)"The long-sought cure to Huntington's disease" (CRG / Cordis)
"The long-sought cure to Huntington's disease" (CRG / Cordis)The long-sought cure to Huntington's disease (CRG / Cordis)
The long-sought cure to Huntington's disease (CRG / Cordis)
The Science to Business (S2B) Concept Challenge fosters again the CRG entrepreneurial spirit
The second edition of the Science to Business (S2B) Concept Challenge is open and ready to receive new ideas...
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)
The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)
CRG Proof of Concept: Commercialization Gap Fund (CGF)
Deadline (Short Submission): 01/09/2016
Please send your application (max. 2 pages) under the following schemes:
- MIDI - Up to 6 months and 35 kEUR
- MAXI - Up to 12 months and 75 kEUR
3rd CRG BioBusiness School (Extended Deadline)
12th-16th September 2016
Based on the great success of the former editions, the 3rd CRG Bio-Business School shall:
- Raise awareness about technology transfer among the participants through lectures and hands-on practical sessions;
- Teach the challenges, opportunities and tools to successfully transfer basic knowledge "from the lab to the marketplace";
- Identify projects with technology transfer/business potential that could otherwise remain undisclosed;
- Match basic science in biomedicine, bioinformatics, etc. with business;
- Have participants function as "signal amplifiers", able to spread the knowledge acquired amongst other colleagues, and apply it to new projects;
- Stimulate a culture of innovation and entrepreneurship.
Registration is free and open online. Click here to register. Deadline (extended) 08 July2016
The TBDO participated in the 2016 BIO International Convention in San Francisco
The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking and partnering meetings to discover new opportunities and promising partnerships.